$2.43
N/A
Last update: Nov 10, 4:00 AM
Alterity Therapeutics Ltd
ATHENASDAQ
The average analyst price target for Alterity Therapeutics is $10.67, 344.6% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $4 to $16. The latest change came on Sep 15, 2026, when Lake Street initiated coverage of Alterity Therapeutics with a Buy rating and a $10 price target.
Price Target Range — 5 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
